Affected by the late development of the market and the medical system, China's third-party medical testing industry is still in the early stage of development, and the overall market size is small. At present, the market for third-party medical diagnosis in China is less than 2 billion yuan, accounting for only 1%-2% of the total medical diagnosis. And China's third-party medical diagnostic market can only test more than 1,000 projects, while foreign developed countries such as the United States can reach more than 4,000. The gap in medical diagnostics is obviously especially in the gene/molecular diagnostics market segment.
At present, there are about 110 laboratories engaged in third-party medical diagnosis in China, but most of them are small. Jinyu, Dean, Hangzhou Aidi Kang and Gaoxin Daan (Daan Gene Investment) are leading enterprises in the third-party medical diagnosis industry in China, with a total market share of about 70%, and these four companies are chain operations. Comprehensive diagnostic service model. While Beijing Yongzheng Xinggang, Beijing Dino, Hangzhou Zhiyuan and other enterprises account for a relatively small market share, they also occupy a certain market position with special diagnostic services.
Affected by the favorable policies of the downstream market and the encouragement of the development of private medical institutions, foreign investment in the third-party medical diagnostic market in China is growing. At present, many foreign companies have entered the third-party medical diagnostic market in China through technical cooperation or direct capital injection.
In early 2012, Daan Gene (002030) and Life Technologies jointly established Guangzhou Lifidaan Diagnostics Products Technology Co., Ltd. and announced the official launch of the gene sequencing molecular diagnostic project.
In February 2012, Shenzhen Hua test and hand in hand Amcare International Medical Laboratory, established a joint venture company in Shanghai, Johns Hopkins (China) Medical Laboratories (joint venture company registered capital of 10 million US dollars, the shareholding ratio of the two parties is 51% and 49%) Third-party medical testing services.
In March 2012, Kangsheng Global (Beijing) received a $20 million Series C investment with KPCB China, WI Harper Group, Baird Capital Partners Asia and Mayo Clinic. Among them, the latter three companies also participated in the B round of 11 million US dollars investment in Kangsheng Global (Beijing) in June 2011.
Medical protective masks are masks made of one or more fabrics that have isolation effects on viral aerosols, virus-containing liquids, and so on. Under the respiratory airflow, it still has a barrier effect on viral aerosols, virus-containing liquids, etc., and when removed, the outer surface of the mask does not contact the human body, can filter particulates in the air, and block droplets, blood, body fluids, secretions, etc. . The use of medical masks includes adhesion testing, training, model selection, medical treatment and maintenance.
Function and composition: The medical protective mask consists of a mask face and a tightening belt. The mask face is divided into three layers: inner, middle and outer. The inner layer is ordinary sanitary gauze or non-woven fabric. Propylene fiber melt-blown material layer, the outer layer is non-woven fabric or ultra-thin polypropylene melt-blown material layer. This high-efficiency medical protective mask is highly hydrophobic and breathable, and has a significant filtering effect on tiny virus-carrying aerosols or harmful fine dust, and the overall filtering effect is good.
The medical protective mask has a good fit with the wearer's face, can filter particles in the air, block pollutants such as droplets, blood, body fluids, secretions, etc., and can filter non-oily particles by more than 95% Personal protective equipment commonly used to deal with airborne diseases.
Scope of application: Medical protective masks are better protective products. It is recommended to wear when there is serious environmental pollution or sudden medical infectious diseases (such as respiratory tract infectious diseases), to prevent the spread of viruses from patients or the environment to users.
Product specifications: According to the national standard GB 19083-2003 "Technical Requirements for Medical Protective Masks", important performances of medical protective masks include filtration efficiency, adhesion, liquid barrier performance, comfort, hygiene, and biological safety tests.
Important technical indicators: including non-oily particle filtration efficiency and airflow resistance.
(1) Filtration efficiency: Under the condition of air flow (85 ± 2) L / min, the filtration efficiency of aerodynamic median diameter (0.24 ± 0.06) μm sodium chloride aerosol is not less than 95%.
(2) Tightness: The overall fit factor of the mask should not be less than 100.
How to use: How to wear a head mask
(1) Gently pinch the nose clip and place the mask on the face to ensure that it can cover the nose and mouth.
(2) The upper elastic band is fastened on the head to prevent air from entering.
(3) Tighten the lower elastic band around the neck.
(4) Be sure to fully open the mask to minimize the number of layers used during breathing.
How to wear earhook masks
(1) Pass the ear straps with both hands, place the nose clip on the upper part, and wear the mask on the nose and mouth
(2) The ear strap should be placed at the base of the ear and spread from head to toe, so that the folds of the mask are fully unfolded, which helps to cover the face to the greatest extent and minimize the number of layers required for breathing.
(3) Gently pinch the nose clip to prevent air from entering.
Protective Mask,Medical Protective Mask,Disposable Medical Protective Mask,Disposable Medical Protective Face Mask
Guangzhou Aikangli Medical Technology Co., Ltd. , https://www.aikanli.com